The MOST Device has been listed with the FDA as a class 1 product available for sale.
Swallow Solutions, based in Madison, Wis., intends to launch a second generation of the MOST device.
More Articles on Gastroenterology:
Test to Detect Multiple Causes of Gastroenteritis Receives FDA Approval
Study Evaluates Efficacy of LINX Magnetic Device for Reflux Disease
Phenomenome Discoveries Develops Test to Identify Patients at Risk of Colon Cancer
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
